Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. The genetic landscape of 87 ovarian germ cell tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Non-aspirin NSAID use and ovarian cancer mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The genetic landscape of 87 ovarian germ cell tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: The aim of this systematic review is to analyze data on risk factors, epidemiology, clinicopathology and molecular biology from studies comparing primary peritoneal cancer, fallopian tube cancer and ovarian cancer of serous histology, in order to achieve a greater understanding of whether or not these disorders should be considered as separate entities.

METHODS: A systematic literature search was conducted in PubMed and MEDLINE. Case-control studies comparing primary serous peritoneal or fallopian tube carcinomas with primary serous ovarian carcinomas or a control group were included.

RESULTS: Twenty-eight studies were found eligible. Primary peritoneal cancer patients were older, had higher parity, were more often obese and had poorer survival compared to ovarian cancer patients. Differences in protein expression patterns of Her2/neu, estrogen and progestin receptors and frequency of loss of heterozygosity differed between primary peritoneal cancer and primary ovarian cancer patients. No major differences were found between primary fallopian tube cancer and primary ovarian cancer. The proportion of serous tubal intraepithelial carcinomas (STIC) was lower in primary peritoneal cancer and primary ovarian cancer compared to primary fallopian tube cancer.

CONCLUSION: Except from differences in the proportion of STIC only few differences between primary fallopian tube cancer and primary ovarian cancer have been found. In contrast, observed differences in risk factor profile, clinicopathologic and prognostic factors, as well as in the molecular patterns, indicate that peritoneal cancer and ovarian cancer may be linked to different carcinogenic pathways.

Original languageEnglish
JournalGynecologic Oncology
Volume136
Issue number3
Pages (from-to)571-81
Number of pages11
ISSN0090-8258
DOIs
Publication statusPublished - Mar 2015

    Research areas

  • Biomarkers, Tumor, Fallopian Tube Neoplasms, Female, Global Health, Humans, Ovarian Neoplasms, Peritoneal Neoplasms, Prognosis, Risk Factors, Survival Rate

ID: 46194408